Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction

被引：18

作者：

D'Arcy, Padraig ^{[1
,2
]}

Ryan, Brid Ann ^{[2
]}

Brodin, Bertha ^{[1
]}

机构：

[1] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, Stockholm 17176, Sweden

[2] Dublin Inst Technol, Dept Biol Sci, Dublin 8, Ireland

来源：

CANCER LETTERS | 2009年 / 275卷 / 02期

关键词：

Synovial sarcoma; SS18-SSX; p53; HDM2; Nutlin-3; CHRONIC LYMPHOCYTIC-LEUKEMIA; MOLECULE MDM2 ANTAGONISTS; PROGNOSTIC-FACTORS; ONCOPROTEIN MDM2; TRANSLOCATION; PATHWAY; PROTEIN; ACTIVATION; NUTLIN-3A; SYT-SSX1;

D O I：

10.1016/j.canlet.2008.10.030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mutations of the p53 gene are relatively rare in synovial sarcoma. With this in mind we investigated the potential of the HDM2 antagonist, nutlin-3 to induce p53 activity in synovial sarcoma cells lines. Nutlin-3 effectively promoted p53 stability which was concurrent with the activation of p53 target genes, growth arrest and apoptosis. Analysis of synovial sarcoma cells showed that p53 is effectively stabilized in response to DNA damage; however transcriptional activation of p53 target genes p21 and HDM2 is abrogated. Co-immunoprecipitation studies showed the presence of high levels of p53-HDM2 complexes in doxorubicin but not nutlin-3 treated cells suggesting that HDM2 association is responsible for the loss of p53 activity, Our results support the hypothesis that p53 function is suppressed by aberrant HDM2 activity and suggest the possibility of targeting the p53-HDM2 regulatory axis as a therapeutic strategy in synovial sarcoma. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：285 / 292

页数：8

共 35 条

[1] A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells [J].

Arva, NC ;

Gopen, TR ;

Talbott, KE ;

Campbell, LE ;

Chicas, A ;

White, DE ;

Bond, GL ;

Levine, AJ ;

Bargonetti, J .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) :26776-26787

[2] Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases [J].

Barlev, NA ;

Liu, L ;

Chehab, NH ;

Mansfield, K ;

Harris, KG ;

Halazonetis, TD ;

Berger, SL .

MOLECULAR CELL, 2001, 8 (06) :1243-1254

[3] A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [J].

Bond, GL ;

Hu, WW ;

Bond, EE ;

Robins, H ;

Lutzker, SG ;

Arva, NC ;

Bargonetti, J ;

Bartel, F ;

Taubert, H ;

Wuerl, P ;

Onel, K ;

Yip, L ;

Hwang, SJ ;

Strong, LC ;

Lozano, G ;

Levine, AJ .

CELL, 2004, 119 (05) :591-602

[4] An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 [J].

Boyd, SD ;

Tsai, KY ;

Jacks, T .

NATURE CELL BIOLOGY, 2000, 2 (09) :563-568

[5] IDENTIFICATION OF NOVEL GENES, SYT AND SSX, INVOLVED IN THE T(X18)(P11.2Q11.2) TRANSLOCATION FOUND IN HUMAN SYNOVIAL SARCOMA [J].

CLARK, J ;

ROCQUES, PJ ;

CREW, AJ ;

GILL, S ;

SHIPLEY, J ;

CHAN, AML ;

GUSTERSON, BA ;

COOPER, CS .

NATURE GENETICS, 1994, 7 (04) :502-508

[6] MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells [J].

Coll-Mulet, Llorenc ;

Iglesias-Serret, Daniel ;

Santidrian, Antonio F. ;

Cosialls, Ana M. ;

de Frias, Merce ;

Castano, Esther ;

Campas, Clara ;

Barragan, Montserrat ;

Fernandez de Sevilla, Alberto ;

Domingo, Alicia ;

Vassilev, Lyubomir T. ;

Pons, Gabriel ;

Gil, Joan .

BLOOD, 2006, 107 (10) :4109-4114

[7] The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability [J].

D'Arcy, Padraig ;

Maruwge, Wessen ;

Ryan, Brid Ann ;

Brodin, Bertha .

MOLECULAR CANCER RESEARCH, 2008, 6 (01) :127-138

[8] The synovial sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (De)regulation [J].

de Bruijn, Diederik R. H. ;

Allander, Susanne V. ;

van Dijk, Anke H. A. ;

Willemse, Marieke P. ;

Thijssen, Jose ;

van Groningen, Jan J. M. ;

Meltzer, Paul S. ;

van Kessel, Ad Geurts .

CANCER RESEARCH, 2006, 66 (19) :9474-9482

[9] IDENTIFICATION OF 2 ALTERNATIVE FUSION GENES, SYT-SSX1 AND SYT-SSX2, IN T(X-18)(P11.2-Q11.2)-POSITIVE SYNOVIAL SARCOMAS [J].

DELEEUW, B ;

BALEMANS, M ;

WEGHUIS, DO ;

VANKESSEL, AG .

HUMAN MOLECULAR GENETICS, 1995, 4 (06) :1097-1099

[10] Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma [J].

Drakos, Elias ;

Thomaides, Athanasios ;

Medeiros, L. Jeffrey ;

Li, Jiang ;

Leventaki, Vasiliki ;

Konopleva, Marina ;

Andreeff, Michael ;

Rassidakis, George Z. .

CLINICAL CANCER RESEARCH, 2007, 13 (11) :3380-3387

← 1 2 3 4 →